Onkologie. 2009:3(1):7-11
A brief overview of epidemiology of malignant breast neoplasm in the Czech Republic
- 1 Institut biostatistiky a analýz, Masarykova univerzita, Brno
- 2 ředitel Institutu biostatistiky a analýz Masarykovy univerzity v Brně
- 3 Onkologické oddělení FTN, Praha
Malignant diseases present a serious health challenge for the Czech population, particularly with respect to the increasing number of
newly diagnosed cancer patients each year. Breast cancer is the most important cancer in women. In long-term view, there has been an
upward trend in breast cancer incidence, with stagnation in recent years. In 2005, 5 533 new cases of breast cancer were diagnosed among
Czech women, representing 105.4 malignant tumours per 100 000 women, or 17 % of all newly diagnosed malignancies in women. In
contrast to this, breast cancer mortality has stagnated in the long term; 1 916 women died in 2005 (36.5 per 100 000 women), while the
prevalence reached 49 539 women with breast cancer (944 per 100 000 women).
Breast cancer occurs predominantly in women over 40 years; 50 % of cancers are diagnosed between 53 and 73 years of age, the median
age being 62 years. Generally, there have been growing incidence trends in this age group, while stagnation has been reported for
women under 40.
Early detection is one of the key factors for a good prognosis of this disease. The proportion of early-detected tumours has steadily increased,
reaching 70–73 % over the last few years – particularly due to the ongoing breast cancer screening programme. It is therefore
expected that positive trends in epidemiology and in treatment success will continue in future.
Keywords: malignant breast neoplasm; epidemiology of tumours; National Oncology Registry.
Published: March 1, 2009 Show citation
References
- Abrahámová J, Dušek L (eds). Metody včasného záchytu karcinomu prsu. Grada Publishing a.s., Praha 2003: 227 s.
- Demografické údaje České republiky a Databáze zemřelých České republiky, Český statistický úřad.
- Dušek L, Mužík J, Kubásek M, et al. Epidemiologie zhoubných nádorů v České republice (online). Masarykova univerzita, 2005, cit. 2008-8-26. Dostupný z www: http://www.svod.cz. Verze 7.0 (2007), ISSN 1802-8861.
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0, IARCPress, Lyon, 2004, http://www-dep.iarc.fr.
- ICD-O-2: International Classification of Diseases for Oncology, 2nd Edition, World Health Organization, 1990; MKN-O-2: Mezinárodní klasifikace nemocí pro onkologii, Druhé vydání, Česká verze, Ústav zdravotnických informací a statistiky ČR, Praha 1994.
- International Union Against Cancer (UICC): TNM Classification of malignant tumours. 5th ed. Sobin LH, Wittekind Ch (ed.), New York, Wiley-Liss. 1997; TNM klasifikace zhoubných novotvarů, 5. vydání 1997, Česká verze, Ústav zdravotnických informací a statistiky ČR, Praha 2000, ISBN 80-7280-025-6.
- Mamografický screening v České republice. (online), (cit. 2008-8-26), Dostupný z www: http://www.mamo.cz.
- Národní onkologický registr České republiky, Ústav zdravotnických informací a statistiky ČR, data z let 1977-2005.
- Tumours of the breast and female genital organs, WHO classification of tumours, 2003, ISBN 92-832-2412-4.
- Ústav zdravotnických informací a statistiky ČR, Novotvary (Cancer Incidence in the Czech Republic); vydáváno každoročně, poslední vydání: rok 2005, ISBN 978-80-7280-723-9, dostupné z http://www.uzis.cz/download.php?ctg=10&search_name=Novotvary®ion=100&kind=1&mnu_id=5300.